Increased LAG‐3, TIM‐3, and IDO1 Expression Is Associated With Oral Squamous Cell Carcinoma in Never Smokers and Never Drinkers
Oral Diseases · 2026
DOI: 10.1111/odi.70301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2026. Verfasst von Mathias Fiedler und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany. Hauptthemen laut MEDLINE: Indoleamine-Pyrrole 2,3,-Dioxygenase, Hepatitis A Virus Cellular Receptor 2, Mouth Neoplasms, Carcinoma, Squamous Cell. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
Background
Immune checkpoints such as, LAG‐3, TIM‐3, and IDO1 have emerged as potential therapeutic targets beyond PD‐1/PD‐L1 blockade. Their expression patterns in oral squamous cell carcinoma, especially among patients without smoking or alcohol exposure, remain poorly understood.
Methods
Immunohistochemical expression of LAG‐3, TIM‐3, and IDO1 was examined in 130 oral squamous cell carcinoma specimens. Expression levels were correlated with clinicopathological features, immune infiltration (CD4 + , CD8 + , FoxP3 + , CD1a + ), PD‐1/PD‐L1 status, and smoking and drinking history. Tumors co‐expressing all checkpoints (LAG‐3 + /TIM‐3 + /IDO1 + /PD‐L1 + ) were classified as “comprehensive checkpoint‐positive.” Results High LAG‐3, TIM‐3, and IDO1 expression was significantly associated with never‐smoking/never‐drinking status ( p ≤ 0.039) and increased CD4 + , CD8 + , and FoxP3 + T‐cell densities ( p ≤ 0.015). All markers showed strong correlations with PD‐1/PD‐L1 and with each other ( p ≤ 0.002). The comprehensive checkpoint‐positive phenotype occurred in 16.8% of cases, more often in never‐smoking/never‐drinking patients ( p = 0.011), females ( p = 0.026), and well‐differentiated tumors ( p = 0.007).
Conclusion
Co‐expression of LAG‐3, TIM‐3, and IDO1 characterizes an immune‐active but potentially exhausted microenvironment, particularly in never‐smoking, never‐drinking oral squamous cell carcinoma. This pattern may define an immunologically distinct subtype with possible relevance for combinatorial immunotherapy approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, University Hospital Regensburg, Regensburg, Germany.
- Department of Oral and Maxillofacial Surgery, Center for Medical Biotechnology, University Hospital Regensburg, Regensburg, Germany.
- Institute of Pathology, University of Regensburg, Regensburg, Germany.
- Center of Tumor Registry, University of Regensburg, Regensburg, Germany.
ORCID-Profile: Mathias Fiedler, Tobias Ettl
Zitieren
APA
Fiedler, M., Off, A., Eichberger, J., Gottsauner, M., Schuderer, J. G., Maurer, M., Eckmüller, S., Himmelstoß, K., Bauer, R. J., Gerken, M., Reichert, T. E., Weber, F., & Ettl, T. (2026). Increased LAG‐3, TIM‐3, and IDO1 Expression Is Associated With Oral Squamous Cell Carcinoma in Never Smokers and Never Drinkers. Oral Diseases. https://doi.org/10.1111/odi.70301
Vancouver
Fiedler M, Off A, Eichberger J, Gottsauner M, Schuderer JG, Maurer M, et al. Increased LAG‐3, TIM‐3, and IDO1 Expression Is Associated With Oral Squamous Cell Carcinoma in Never Smokers and Never Drinkers. Oral Diseases. 2026. doi:10.1111/odi.70301
BibTeX
@article{Fiedler2026,
author = {Fiedler, Mathias and Off, Alisa and Eichberger, Jonas and Gottsauner, Maximilian and Schuderer, Johannes G and Maurer, Michael and Eckmüller, Stephanie and Himmelstoß, Katja and Bauer, Richard J and Gerken, Michael and Reichert, Torsten E and Weber, Florian and Ettl, Tobias},
title = {Increased LAG‐3, TIM‐3, and IDO1 Expression Is Associated With Oral Squamous Cell Carcinoma in Never Smokers and Never Drinkers},
journal = {Oral Diseases},
year = {2026},
doi = {10.1111/odi.70301}
}
EUVIMED